From: Low expression of RECQL is associated with poor prognosis in Chinese breast cancer patients
Variable | DDFS | DSS | ||||
---|---|---|---|---|---|---|
HR | 95% CI | P | HR | 95% CI | P | |
Age | Â | Â | Â | Â | Â | Â |
 > 50 yr. vs. ≤50 yr | 0.56 | 0.29–1.07 | 0.08 | 0.34 | 0.13–0.92 | 0.033 |
ER status | Â | Â | Â | Â | Â | Â |
 Negative vs. Positive | 1.01 | 0.49–2.06 | 0.99 | 0.58 | 0.19–1.75 | 0.33 |
PR status | Â | Â | Â | Â | Â | Â |
 Negative vs. Positive | 0.82 | 0.39–1.72 | 0.60 | 0.86 | 0.30–2.50 | 0.79 |
HER2 status | Â | Â | Â | Â | Â | Â |
 Positive vs. Negative | 1.72 | 0.80–3.73 | 0.17 | 4.23 | 1.60–11.46 | 0.004 |
Tumor size | Â | Â | Â | Â | Â | Â |
 > 2 cm vs. ≤2 cm | 0.76 | 0.40–1.42 | 0.39 | 1.01 | 0.41–2.50 | 0.98 |
Lymph node status | Â | Â | Â | Â | Â | Â |
 Positive vs. Negative | 2.68 | 1.43–5.03 | 0.002 | 3.68 | 1.39–9.75 | 0.009 |
Adjuvant chemotherapy | Â | Â | Â | Â | Â | Â |
 C vs. no therapy | 1.71 | 0.38–7.79 | 0.49 | 1.46 | 0.29–7.29 | 0.64 |
 E vs. no therapy | 2.53 | 0.44–14.62 | 0.30 | 1.67 | 0.20–13.69 | 0.63 |
 C + E vs.no therapy | 2.11 | 0.47–9.47 | 0.33 | 0.92 | 0.17–5.01 | 0.63 |
RECQL protein expression | Â | Â | Â | Â | Â | Â |
 Low vs. High | 2.12 | 1.16–3.88 | 0.015 | 2.09 | 0.85–5.13 | 0.06 |